← Back to Search

Limited Ultrasound Imaging for Developmental Dysplasia of the Hip

N/A
Waitlist Available
Led By Simon P Kelley, PhD, FRCS
Research Sponsored by The Hospital for Sick Children
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Aged 0-6 months at time of diagnosis
Clinical and Ultrasound diagnosis of stable developmental dysplasia of the hip
Timeline
Screening 3 weeks
Treatment Varies
Follow Up when patient reaches 1 year of age
Awards & highlights

Study Summary

This trial is testing whether skipping some ultrasound appointments during treatment for DDH will have the same outcome and be more efficient.

Eligible Conditions
  • Developmental Dysplasia of the Hip

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~when patient reaches 1 year of age
This trial's timeline: 3 weeks for screening, Varies for treatment, and when patient reaches 1 year of age for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acetabular Index
International Hip Dysplasia Institute Score
Secondary outcome measures
Complication Rate
Health Care Costs
Hospital Appointment Duration

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Limited Ultrasound GroupExperimental Treatment1 Intervention
Children in the limited ultrasound protocol group will receive the same treatment as described for the comprehensive ultrasound group above, except the ultrasound imaging conducted at weeks 2, 5 and 8 will be omitted. Children will still return to clinic at 2, 5, and 8 weeks for clinical examination, which includes the assessment of the Pavlik harness fit and screening for complications.
Group II: Comprehensive Ultrasound GroupActive Control1 Intervention
Children in the comprehensive ultrasound protocol group will follow the current standardized treatment protocol used at the Hospital for Sick Children in Toronto, Canada. For children presenting with stable hip dysplasia, Pavlik harness (PH) treatment is initiated at the initial visit (week 0) and runs for a total of 12 weeks. Children return to clinic at weeks 2, 5, 8 and 12 for clinical and ultrasound examinations to ensure that the harness is fitting correctly, to screen for PH complications and to monitor acetabular development.

Find a Location

Who is running the clinical trial?

The Hospital for Sick ChildrenLead Sponsor
682 Previous Clinical Trials
6,945,234 Total Patients Enrolled
1 Trials studying Developmental Dysplasia of the Hip
Simon P Kelley, PhD, FRCSPrincipal InvestigatorThe Hospital for Sick Children, Toronto, Ontario, Canada

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this medical experiment currently have openings for new participants?

"Clinicaltrials.gov indicates that this clinical trial, initially posted on July 27th 2018 and most recently updated on June 8th 2022, is no longer recruiting patients. Nevertheless there are 26 other ongoing studies currently welcoming participants."

Answered by AI
~15 spots leftby Mar 2025